[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367974-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367974-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","per3-suppresses-lung-adenocarcinomatous-cell-proliferationmigration-through-activating-ampkmtor-pathway","PER3 suppresses lung adenocarcinomatous cell proliferation/migration through activating AMPK/mTOR pathway","","PER3 circadian regulator 3 (PER3) is investigated for its biological roles in lung adenocarcinoma development and progression and the underlying mechanisms linking circadian dysregulation to cancer risk. PER3 expression is decreased in lung adenocarcinoma and low levels associate with more advanced disease stages. PER3 overexpression inhibits proliferation, migration, and invasion, while PER3 silencing has opposite effects. PER3 modulates AMPK and mTOR phosphorylation, and AMPK/mTOR inhibitors or activators partially reverse these cellular outcomes, supporting PER3 as a biomarker and therapeutic target.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/per3-suppresses-lung-adenocarcinomatous-cell-proliferationmigration-through-activating-ampkmtor-pathway/367974/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/per3-suppresses-lung-adenocarcinomatous-cell-proliferationmigration-through-activating-ampkmtor-pathway/367974.png","ImageObject",300,407,{"name":42,"@type":43},"kopisore","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How is PER3 expression related to lung adenocarcinoma progression?","Question",{"text":63,"@type":64},"PER3 expression is decreased in lung adenocarcinoma, and low PER3 levels correlate with advanced disease stages.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What effects do PER3 overexpression and silencing have on lung adenocarcinomatous cells?",{"text":68,"@type":64},"PER3 overexpression inhibits proliferation, migration, and invasion, whereas PER3 silencing promotes these malignant behaviors.",{"name":70,"@type":61,"acceptedAnswer":71},"How does the AMPK/mTOR pathway mediate PER3’s cellular effects?",{"text":72,"@type":64},"PER3 overexpression elevates AMPK phosphorylation and reduces mTOR phosphorylation, and the AMPK/mTOR inhibitor partially reverses PER3-driven inhibition; AMPK/mTOR activation partially reverses the promotion caused by PER3 silencing.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367974,1790211060,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962090880963,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nPER3 suppresses lung adenocarcinomatous cell proliferation/migration through activating AMPK/mTOR pathway  \nGuanli Yuan1,4, Yinfeng Liu2,4, Dawei Wu3 & Jingping Xu1􀀍  \nDysregulation of circadian rhythm genes is related to the increased risk of development of various human cancers. This study investigated the biological roles of Period circadian regulator 3 (PER3) in the development and progression of lung adenocarcinoma and related underlying mechanisms. The expression of PER3 was decreased in lung adenocarcinoma and its low expression was correlated with advanced disease stages. Lentiviral-transduced overexpression of PER3 inhibited but PER3 silencing promoted proliferation, migration and invasion of lung adenocarcinomatous cells, suggesting that it played an anti-carcinogenic role in the development and progression of lung adenocarcinoma. Mechanistically, PER3 overexpression elevated the phosphorylation level of AMPK and reduced the phosphorylation level of mTOR, but PER3 silencing produced the opposite effects. More importantly, the inhibitory effects of PER3 overexpression on cellular proliferation, migration and invasion were partially reversed by the AMPK/mTOR pathway inhibitor. Correspondingly, the promoting effects of PER3 silencing on proliferation, migration and invasion was partially reversed by the AMPK/mTOR pathway activator. These findings collectively suggest that PER3 regulated biological behaviors of lung adenocarcinomatous cells through activating the AMPK/mTOR pathway. PER3 may be a promising biomarker and therapeutic target for lung adenocarcinoma.  \nKeywords Lung adenocarcinoma, Period circadian regulator 3 (PER3), AMPK/mTOR pathway  \nAbbreviations  \nNSCLC Non small cell lung cancer PER3 Period circadian regulator 3 MOI Multiplicity of infection EdU 5-Ethynyl-2’-Deoxyuridine  \nRIPA Radioimmunoprecipitation assay SD Standard deviation  \nNon-small cell lung cancer (NSCLC) is the most common histological type of lung cancer, and one type of NSCLC is adenocarcinoma1. Due to aggressive behavior of cancer cells, patients with lung adenocarcinoma are usually diagnosed at an advanced stage, resulting in a poor survival rate2–4. The lack of specific diagnostic and prognostic biomarkers is an urgent problem that need be addressed in the clinical management of patients with lung adenocarcinoma. Identifying valuable biomarkers will advance our understanding of molecular mechanisms of carcinogenesis oflung adenocarcinoma and further optimize treatment strategies.  \nMany physiological and biochemical processes in the human body, including cell cycle, genetic transcription, hormone release, anabolism and catabolism, are regulated by the circadian rhythm5. The circadian rhythm is driven by a series of circadian clock genes, which affect the expression of cytokines and cellular functions6,7. Recently, the increasing body of epidemiologic evidence suggests that mutation or dysregulation of circadian rhythm genes is related to increased risk of the development of various human cancers8,9. Many studies have  \n1Department of General Practice, the First Hospital of Qinhuangdao, Qinhuangdao 050000, Hebei, China.  \n2Department of Breast Disease Center, the First Hospital of Qinhuangdao, Qinhuangdao 050000, Hebei, China.  \n3Department of Oncology and Hematology, Qinhuangdao Integrated Traditional Chinese and Western Medicine Hospital of Hebei Port Group Co., Ltd, Qinhuangdao City 050000, Hebei, China. 4Guanli Yuan and Yinfeng Liu contributed equally to this work. 􀀍 email: JingpingXu_[Qin@126.com](Qin@126.com)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nreported differential expression of circadian rhythm genes in hepatocellular carcinoma, breast cancer and colorectal cancer samples10–12.  \nPeriod circadian regulator 3 (PER3), which is localized in chromosome 1p36, is a major member of the circadian rhythm gene family13.","cbCaihL3f2f0JTrx","https://ap.wps.com/l/cbCaihL3f2f0JTrx","pdf",2607487,11,"English","# Background\n# PER3 in Lung Adenocarcinoma\n# Materials and Methods\n## Data source and bioinformatics analysis\n## Clinical samples and cell culture","[{\"question\":\"How is PER3 expression related to lung adenocarcinoma progression?\",\"answer\":\"PER3 expression is decreased in lung adenocarcinoma, and low PER3 levels correlate with advanced disease stages.\"},{\"question\":\"What effects do PER3 overexpression and silencing have on lung adenocarcinomatous cells?\",\"answer\":\"PER3 overexpression inhibits proliferation, migration, and invasion, whereas PER3 silencing promotes these malignant behaviors.\"},{\"question\":\"How does the AMPK/mTOR pathway mediate PER3’s cellular effects?\",\"answer\":\"PER3 overexpression elevates AMPK phosphorylation and reduces mTOR phosphorylation, and the AMPK/mTOR inhibitor partially reverses PER3-driven inhibition; AMPK/mTOR activation partially reverses the promotion caused by PER3 silencing.\"}]","PER3 suppresses lung adenocarcinomatous cell proliferation/migration through activating AMPK/mTOR pathway | PDF",1790174043,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/282d828923003732db33b7edb4ac8457.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7a82fa6b945496f3de226875650215a5.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/40e46911b417ec3bdc9aa0e3d48b22e0.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cd7e7d4825b36ddedd66d5bfbfd2ee94.webp",980,1287]